Our overall correlation results show several potential drug repurposing candidates negatively correlating with SARS-CoV-2, varying from corticosteroids such as MP (already approved for treatment of COVID-19 patients), biologicals such as BTK-inhibitors that are currently being studied in clinical trials [37] to metformin [40]. This evidence concerns the gene BTK and COVID-19.